Silphium Asset Management LTD Cytokinetics Inc Transaction History
Silphium Asset Management LTD
- $280 Billion
- Q3 2024
A detailed history of Silphium Asset Management LTD transactions in Cytokinetics Inc stock. As of the latest transaction made, Silphium Asset Management LTD holds 10,000 shares of CYTK stock, worth $486,500. This represents 0.19% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$486,500
Previous $542 Million
2.55%
% of portfolio
0.19%
Previous 0.26%
Shares
4 transactions
Others Institutions Holding CYTK
# of Institutions
404Shares Held
124MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$714 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$572 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$471 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$378 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$314 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.58B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...